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Abstract
Objective: To assess the association between change in walking speed over a 12-month period 
and risk of developing radiographic knee osteoarthritis (rKOA) over a 24-month period.
Methods: We included participants without rKOA from the Osteoarthritis Initiative. Change in 
walking speed was determined from a 20-meter walk assessment, calculated using walking speed 
at 12-month follow-up minus baseline speed and/or 24-month follow-up walking speed minus 12-
month speed. Incident rKOA was defined as progressing to Kellgren-Lawrence grade ≥2 within 24 
months (i.e., incidence between 12 and 36 or 24 and 48 months). Self-reported significant knee 
injury during the exposure period, age, body mass index (BMI), and Physical Activity Scale for 
the Elderly (PASE) score were adjusted for analytically.
Results: We included 2,638 observations among 1,460 unique participants (58% female; 59±9 
years, range: 45–79). The mean change in walking speed over 12 months was 0.001±0.13 m/s 
(range: −0.6271, 1.4968). Approximately 5% of the sample (n=122) developed rKOA over a 24-
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month period. After controlling for significant knee injury, age, BMI, and PASE score, we found 
an 8% relative increase in risk of developing rKOA for every 0.1m/s decrease in walking speed 
over a 12-month period (Risk Ratio=1.08; 95% CI =1.00, 1.15; P = 0.05).
Conclusion: Evaluating change in speed over a 12-month period using a 20-meter walk test may 
be useful in identifying individuals at increased risk of developing rKOA over the subsequent 24-
months. Identification of patients at high risk for developing rKOA would allow medical providers 
to implement early interventions to maximize joint health.
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INTRODUCTION
Knee osteoarthritis is the 11th leading cause of global disability.1 There are no disease 
modifying interventions for knee osteoarthritis. One explanation for our failure to identify a 
disease modifying intervention is that we primarily test patients late in the disease process 
when it may be too late. Therefore, early identification of risk factors associated with the 
incidence and progression of knee osteoarthritis has become paramount in preventing 
disease onset or progression as well as associated physical disability.2,3 Clinical strategies 
are needed that can be easily implemented to predict the incidence of knee radiographic 
osteoarthritis (rKOA). Reliable and efficient clinical measures would be beneficial that 
identify individuals at increased risk of developing knee rKOA.
Walking speed is a readily-observable and stable objective measure of physical function. 
Habitual walking speed is typically a stable measure that only varies 1% per decade on 
average until individuals reach approximately 62 years of age.4 Individuals with 
symptomatic knee osteoarthritis demonstrate a rapid decrease in walking speed of as much 
as 2.75% per year.5 Decreased walking speed is associated with decreased confidence in 
knee function6 in those with knee osteoarthritis and predicts the likelihood that an individual 
with knee osteoarthritis will elect to undergo a knee replacement.7 In addition, slower 
walking speed associates with higher concentrations of serum-based markers of type-II 
collagen breakdown in individuals following anterior cruciate ligament reconstruction,8 who 
are at higher risk of developing knee rKOA.9–11
Previous authors have demonstrated that slower habitual walkers without knee rKOA 
demonstrated higher odds of developing rKOA at 6-year follow-up.12 However, change in 
walking speed may provide a more sensitive measure of future osteoarthritis risk than an 
assessment of gait pace at a single time point. To date no prospective studies have examined 
longitudinal changes in walking speed and risk of rKOA. The ability to predict an 
individual’s risk of developing knee rKOA by measuring a change in walking speed may 
provide clinicians with a cost effective measurement tool that could be employed at 
subsequent clinic visits. While walking speed is known to decrease in those with 
symptomatic knee osteoarthritis,5 it remains unknown if a decrease in walking speed among 
those without rKOA over one year is identifiable prior to knee rKOA development or 
progression.
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The overall goal of our analysis was to determine whether changes in a simple 20-meter 
walk test, evaluated during annual clinical exams, could be used as a marker of those who 
will develop knee rKOA within the following two years. To accomplish this goal, we assess 
the association between a change in walking speed over a 12-month period among individual 
without osteoarthritis and the risk of developing knee rKOA over a subsequent 24-month 
period using data from the Osteoarthritis Initiative (OAI). We hypothesized that a decrease 
in walking speed over a 12-month period would be associated with an increase in knee 
rKOA risk over the subsequent 24 months.
PATIENTS AND METHODS
Study Design
Data used in the preparation of this article were obtained from the Osteoarthritis Initiative 
(OAI) database, which is available for public access at www.oai.ucsf.edu.13. Briefly, the OAI 
is a multi-center, longitudinal, prospective observational study of knee osteoarthritis in the 
United States13. Clinical staff recruited 4,796 men and women between the ages of 45 to 79 
years who primarily had symptomatic knee osteoarthritis or were at increased risk for 
developing symptomatic knee osteoarthritis between February 2004 and May 200613. For 
our analyses, we used data from the OAI baseline and first four annual follow-up visits (12-
month through 48-month follow-up). This study was approved by the University of North 
Carolina at Chapel Hill Institutional Review Board under IRB 16–1678.
Inclusion Criteria
We included OAI participants without tibiofemoral rKOA in both knees (Kellgren-Lawrence 
[KL] grade ≤1) and who had at least two walking speed assessments, separated by 12 
months, prior to the 24-month OAI visit (Figure 1). Eligible participants also needed to have 
knee radiographs scored during the exposure period and at the OAI visit that occurred 24 
months after the last assessment of walking speed. Participants were excluded if they 
demonstrated rKOA in either knee at any time during exposure assessment or if they had any 
knee arthroplasty in either knee, had any hip arthroplasty in either hip, had any type of 
prosthesis surrounding the knee, or reported using an ambulatory aid other than a single 
straight cane for more 50% of their time during ambulation. We excluded participants with a 
self-reported history or clinical suspicion of rheumatoid arthritis during our study period.
Walking Speed
The 12-month change in walking speed was determined from the pace of a 20-meter walk 
assessment, using the “AllClinical” files. The 20-meter walking speed assessment has been 
recommended to assess physical function in individuals with r KOA.14 Participants were 
instructed to walk at their usual walking speed from the start to finish points of marked 20-
meter distance.15 As previously reported,15,16 2 trials were collected and the mean of these 
trials was used for data analysis. We included two periods of exposure assessment to 
determine change in walking speed, resulting in two potential observations for each 
participant. Exposure assessment 1 was calculated from the Baseline AllClinical file 
(version 0.2.2) and 12-month AllClinical file (version 1.2.1). Exposure assessment 2 was 
calculated from the 12-month AllClinical file (version 1.2.1) and the 24-month AllClinical 
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file (version 3.2.1). In order to maximize the number of unique assessments of walking 
speed change, walking speed was calculated as a continuous variable from either a) the 
baseline visit to the 12-month follow-up (Exposure Assessment 1: [12-month speed – 
baseline speed]) or b) from the 12-month follow-up to the 24-month follow-up (Exposure 
Assessment 2: [24-month – 12-month speed])(Figure 2). Walking speed was measured in 
meters per second (m/s).
Knee Radiographs
We assessed the incidence of rKOA over 24 months at the 36-month or 48-month OAI visits 
for exposure assessments 1 and 2, respectively (Figure 2). Incident tibiofemoral rKOA was 
determined as having a KL grade ≥ 2 in either knee 24-months following no presence of 
rKOA (KL ≤ 1) at any time during exposure assessment. If either or both knees developed 
rKOA over the 24-months following exposure assessment, that participant’s observation was 
considered to have incident rKOA. Central readers scored KL grades on bilateral weight-
bearing, fixed-flexion posterior-anterior knee radiographs. Readers were blinded to the 
sequence of follow-up images. A study of image assessment in OAI found good reliability 
for KL grading between baseline and 36-month follow-up visit with kappa values of 
approximately 0.70 to 0.80.17 In addition, agreement of readings was similar for the 48-
month follow-up visit radiographs.
Potential Confounders
In order to assess the association between change in walking speed and incident rKOA, we 
included in our initial analysis demographic information on age at baseline, gender, and 
body mass index (BMI) at baseline. Additionally, physical activity level was measured at the 
12-month time point of the exposure assessment using the Physical Activity Scale for the 
Elderly (PASE)(Figure 2).18 Finally, we included information about knee pain, ankle pain, 
back pain, hip pain, knee injury, and history of a fall as potential confounders. Knee, ankle, 
and hip pain were dichotomous variables for self-reported pain, aching or stiffness for more 
than half the days in the past 30 days from the second walking speed assessment. Self-
reported back pain in the past 30 days was also recorded during the 12-month time point of 
the exposure assessment. Knee injury was a dichotomous variable defined as “a serious 
enough knee injury to limit the ability to walk for at least two days” during the 12-month 
exposure assessment period. We also included self-reported history of a fall, which was 
defined as any fall to the floor or ground. All covariates were calculated from the Baseline 
AllClinical file (version 0.2.2), 12-month AllClinical file (version 1.2.1), and 24-month 
AllClinical file (version 3.2.1). Based on the minimally sufficient adjustment set identified 
from a directed acyclic graph, the following confounders were included in our analysis: knee 
injury, age, BMI, and PASE score.
Statistical Analysis
Descriptive statistics were calculated for all variables of interest, including counts and 
proportions for dichotomous variables and means and standard deviations, as well as 
medians and interquartile ranges (IQR), for continuous variables. Comparisons of 
continuous walking speed between those who developed rKOA and those who did not were 
performed using a two-sample t-test due to large sample size and normally distributed data. 
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We determined a priori to assess the linear nature of the relationship prior to formal 
statistical analyses using functional form analysis techniques.
Results of the functional form analysis indicated a relatively linear relationship between 
change in walking speed and incident rKOA. Therefore, multivariable log-binomial 
regression was used to assess the association between continuous walking speed and 
incident rKOA. An adjusted risk ratio was also calculated to estimate the effect of a −0.1m/s 
decrease in walking speed on rKOA incidence (0.10 m/s change in walking speed has 
previously been reported as a the minimal clinically important difference for change in 
walking speed over time) while controlling for the potential confounders (knee injury, age, 
BMI, and PASE score) for our primary analysis.19 An interaction term was added to assess 
potential effect measure modification of the association between walking speed and rKOA 
incidence by reported knee injury. To account for the correlation within participants who 
were included in both exposure assessments, a generalized estimating equation analysis with 
robust standard errors was used. We used Statistical Analysis Software (SAS v 9.4) for all 
analyses with an a priori significance set at p≤0.05.
RESULTS
There were 2,638 12-month walking speed change observations among 1,460 unique 
participants included in this analysis. Descriptive characteristics of the included participants 
are listed in Table 1. Overall, average walking speed increased 0.001± 0.133 m/s (range: 
−0.627, 1.497 m/s) during the 12-month exposure period for observations included in our 
sample. The median change in walking speed was 0.001 m/s (IQR −0.075, 0.075). Walking 
speed decreased in 1,309 (50%) observations, and increased in 1,329 (50%) observations 
over the exposure period.
Approximately 5% of the sample (122 participants) developed rKOA over the 24-month 
period following walking speed. The average 12-month change in walking speed among 
those who developed rKOA was −0.012±0.119m/s compared to 0.002±0.133m/s among 
those who did not develop rKOA (p=0.26). The risk of developing rKOA over 24 months 
was 1.08 times higher (95% CI=0.94, 1.23; p=0.26) for every 0.1 m/s decrease in walking 
speed over a 12-month period. After controlling for significant knee injury, age, BMI, and 
PASE score, we found an 8% relative increase in risk of developing rKOA for every 0.1m/s 
decrease in walking speed over a 12-month period (RR=1.08; 95% CI=1.00 to 1.15; p=0.05)
(Table 2). Among observations where no knee injury was reported (n=2,560), there was an 
8% relative increase in risk of developing rKOA for every 0.1 m/s decrease in walking speed 
over a 12-month period (RR=1.08; 95% CI=1.00 to 1.17; p=0.05); however, among 
observations where an injury was reported (n=75), there was relatively no association 
between a change in walking speed and risk of developing rKOA over a 24-month period 
(RR=1.01; 95% CI=0.83 to 1.23; p=0.91).
DISCUSSION
The results of our study support the hypothesis that individuals who decrease their walking 
speed over a 12-month period in the absence of knee rKOA are at increased risk for 
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developing incident knee rKOA over the following 24-month period. Specifically, we found 
that for every 0.1m/s decrease in walking speed over a 12-month period with no evidence of 
rKOA the relative risk of developing rKOA over the subsequent 24-month period increased 
by 8%, when controlling for significant knee injury, age, BMI, and PASE score. We found 
the same relative increase in risk among participants who did not report a knee injury 
(RR=1.08; 95% CI=1.00 to 1.17; p=0.05); however, among participants who did report a 
knee injury, there was no association between walking speed change and risk of incident 
rKOA (RR=1.01; 95% CI=0.83 to 1.23; p=0.91).
These findings are in line with previous studies that suggested an association between 
habitual walking speed and incident rKOA.12,20 Purser el al.12 analyzed a community-based 
cohort for the effect of average habitual walking speed on the odds of developing rKOA over 
a 6-year period, and found a 12% decrease in odds of developing rKOA for participants with 
a 0.1m/s increase in habitual walking speed. Our study corroborated and added to these 
findings by studying a change in walking speed over time in the absence of knee rKOA, as 
opposed to assessing walking speed at one time point. Therefore a simple, repeated 20-meter 
walk test, which could be easily evaluated during annual clinical exams, could be used to 
indicate increased risk of developing knee rKOA within the following two years, particularly 
among adults without a reported knee injury. This simple indicator may help identify at-risk 
patients, allowing for an opportunity to intervene in order to prevent disease onset and 
associated disability.
Previous work has assessed the ability of walking speed to predict rKOA onset by 
characterizing slow walkers as those with a habitual walking speed of less than 1.00 m/s. 
Others have predicted a clinically meaningful improvement in function over 30 months by 
dichotomizing individuals into those who were and were not able to improve walking speed 
by 1.0m/s. In our cohort, the range of change in walking speed over 12 months was 
−0.627m/s to 1.497m/s, with an average change in walking speed of essentially 0m/s. The 
IQR for change in walking speed in our sample was −0.075m/s to 0.075m/s, suggesting that 
less than 25% of our sample had a change in walking speed greater than 0.1m/s in a 12-
month period. Therefore, the 1.0 m/s change used previously is likely not clinically relevant 
since a very small proportion of people have that drastic of a change in walking speed over 
the course of one year. In contrast, a change of 0.10 to 0.20 m/s in habitual walking speed 
has been identified as a minimally clinically important difference for change in walking 
speed.19 Our data suggested that a decrease of 0.1 m/s over a 12-month period was 
associated with an 8% relative increase in risk of developing rKOA over the subsequent 24 
months. A change of −1.59 seconds has been reported to be the smallest detectable 
difference for the 20-meter walking speed assessment,21 which would be a 0.07 m/s 
decrease in walking speed in individuals who initially walked at 1.00m/s. 21 Therefore, the 
20-meter walking speed assessment appears to demonstrate the appropriate precision to 
detect a change of 0.1m/s in this patient population. The current study also improves upon 
previous research as evaluation of a 0.1m/s change in walking speed over a 12-month period 
assesses risk of developing rKOA in a shorter period of time (over 24 months) compared to a 
previous study that predicted rKOA onset over a 6-year follow-up.12 The ability to provide 
information to patients and providers about increased risk over a shorter period may 
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motivate more immediate further evaluation or lifestyle changes necessary to mitigate the 
risk of rKOA.
While the mechanisms that link slower walking speeds and knee rKOA onset remain 
unknown, it can be hypothesized that slower walking speeds may be a biomechanical 
adaption to the impact of early metabolic changes at the knee.8,12 Slower walking speeds are 
associated with a lesser loading rate and magnitude of loading during the initial peak in the 
ground reaction force during the stance phase of gait.22–25 Greater impulsive loading has 
been found to damage articular cartilage and weaken the extracellular cartilage matrix.26 
Alternatively, it is possible that decreased loading secondary to pain or inactivity may lead to 
deterioration and hasten the osteoarthritis disease process. Decreasing habitual walking 
speed may be a subconscious protective strategy aimed at minimizing the magnitude and 
rate of loading on knee cartilage to maximize the longevity of tissue health. Additionally, 
slower gait speeds may increase the duration in which the knee cartilage is loaded during the 
stance phase of gait.27 While slower speeds decrease the magnitude and loading rate of the 
first half of stance phase, these slower walking speeds increase the magnitude in which the 
extremity is loaded during the second half of the stance phase of gait.23–25 Thereby, slower 
walking speeds and increased magnitude and duration of loading in the second half of the 
stance phase of gait may also cause increased cartilage breakdown. Further research is 
needed to determine if slower walking speeds are protective of deleterious changes in joint 
tissue metabolism prior to rKOA onset or a contributor to these harmful changes that 
influence rKOA onset. Regardless of whether the change in walking speed that was 
appreciated in our study is an early indicator of prevalent osteoarthritis or a causal 
component of its development, we believe our findings are meaningful because these data 
may be used to develop an early clinical indicator of patients who are at risk for developing 
knee rKOA before structural joint changes are detected radiographically.
While our study supports the use of walking speed as a clinical indicator of incident knee 
rKOA, limitations must be considered when interpreting the results of this study. We only 
included participants who completed the longitudinal evaluations, who may be inherently 
different from other participants who did not participate in at least three consecutive study 
visits. Additionally, the results of the current study are most generalizable to a subset of the 
population who meet the OAI inclusion criteria, including increased risk for developing 
osteoarthritis; however, OAI provides a rich dataset that allows for control of potential 
confounders in a large study sample. In addition, this study focused on the development of 
tibiofemoral rKOA, and the results cannot be generalized to patients with patellofemoral 
rKOA. The exposure in this study was change in walking speed over a 12-month period, 
which was measured objectively during clinical 20-meter walk analysis at two time points 
and may not adequately represent the true change in walking speed over a 12-month period. 
Nevertheless, this is a realistic representation of screening of this simple indicator in a 
clinician’s office during annual visits. Overall, very little missing data (<1% for most 
variables) was noted in this analysis with no missing data for either exposure or outcome, 
but there is potential for measurement error for several of the covariates assessed using self-
reported methods (i.e. history of fall, history of knee injury, knee, back, hip, or ankle pain in 
the last 30 days). The outcome of incident rKOA was determined based on radiographic 
assessment, and, as is common in such studies, it was not possible to determine the exact 
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time of rKOA development during the 24-month follow-up period. Additionally, inclusion 
into the study cohort relied on KL grade <2 during the exposure period. While good 
reliability for KL grading between baseline and 36-month follow-up visit (kapp=0.70–0.80) 
was identified in a previous study17, the reliability was lower among KL grade <2. 
Therefore, it is possible that some individuals included in our analysis had existing 
osteoarthritis. It is possible that important potential confounders exist for the relationship 
between walking speed and incident rKOA that were not measured in OAI. Multiple 
previous studies15,16,28 have been published using the 20-meter walk times from the OAI, 
yet we are not aware of any published reliability data on this physical function outcome at 
the different OAI sites. While measuring 20-meter self-selected walking pace is a commonly 
collected clinical outcome of physical performance, a previous study has described a 
learning effect where individuals with rKOA walk faster in the first of three 20-meter 
walking trials compared to the subsequent two. Additionally, the OAI protocol29 does not 
indicate if standardized acceleration and deceleration space was provided to the participants, 
as well as verbal encouragement during the test.
In conclusion, our study found that for every 0.1m/s decrease in walking speed over a 12-
month period, the relative risk of developing rKOA over the subsequent 24-months increased 
by 8%, when controlling for significant knee injury, age, BMI, and PASE score. For 
example, a patient who decreases walking speed by 0.4m/s over a one-year period has 32% 
greater risk of developing rKOA within the next two years compared to a patient with no 
change in walking speed. Evaluating a change in walking speed during serial clinical follow-
ups using a 20-meter walk test may be useful in identifying which patients are at risk for 
developing knee rKOA over the subsequent 24-months. Early identification of these patients 
that are at the highest risk for developing knee OA would allow for medical providers to 
implement early interventions to maximize joint health.
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Figure 1: 
Flow diagram of study enrollment for OAI participants included in the analysis of the 
association between 12-month change in walking speed and 24-month risk for incident 
rKOA
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Figure 2: 
Exposure, outcome, and covariate assessment diagram for participants included in the 
analysis of the association between 12-month change in walking speed and 24-month risk 
for incident rKOA
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Table 1:
Descriptive characteristics for participants include in the analysis of the association between 12-month change 
in walking speed and 24-month risk for incident rOA (N=1,460 participants, 2,638 observations)
Variable N Mean (SD) or n (%) Range
Age (years) 1460 59 (9) 45, 79
BMI (kg/m2) 1460 27.1 (4.5) 17.6, 45.4
Gender 1460
 Male 618 (42%)
 Female 842 (58%)
PASEa Score 2624 166 (82) 7, 464
Knee Pain 2606 685 (26%)
Ankle Pain 2624 236 (9%)
Back Pain 2632 442 (17%)
Hip Pain 2626 624 (24%)
Knee Injury 2635 75 (3%)
History of Fall 1211 380 (31%)
a
Physical Activity Scale for the Elderly (PASE) validated patient-reported outcome score for function
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Table 2:
Multivariable log-binomial regression results and comparison of covariates for participants who developed 
incident rOA over the 24-month study period compared to those who did not (N=1,460 participants, 2,638 
observations)
Variable
Incident rOA No rOA
RR 95%CI
N Mean (SD) or n (%) N Mean (SD) or n (%)
Walking Speed 122 −0.0121 (0.1188) 2516 0.0016 (0.1335) 1.08 1.00, 1.15
Age (years) 122 59.3 (8.4) 2516 59.0 (9.0) 1.00 0.98, 1.03
BMI (kg/m2) 122 28.3 (4.9) 2516 27.0 (4.4) 2.03 1.33, 3.10
PASEa Score 122 162.7 (87.5) 2501 166.5 (82.0) 1.00 1.00, 1.00
Knee Injury 122 8 (6.5) 2513 67 (2.7) 1.38 0.76, 2.49
a
Physical Activity Scale for the Elderly (PASE) validated patient-reported outcome score for function
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